Variables | Univariate Analyses | Multivariate Analysis | ||||
---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95%CI | P-value | |
Original mutation; absent vs. present | 42.2 | 4.77–373.6 | 0.001 | NI | ||
Bone metastases; absent vs. present | 48.8 | 5.45–436.4 | 0.001 | 77.9 | 5.32–1140 | 0.001 |
Enlargement of Tumor size; < 12 mm vs 12 mm ≤ | 0.10 | 0.02–0.43 | 0.002 | NI | ||
Brain metastases; absent vs. present | 7.39 | 1.77–30.8 | 0.006 | NI | ||
Detection of New tumor lesion; < 4 vs 4 ≤ | 7.39 | 1.77–30.8 | 0.006 | 14.5 | 1.38–151.2 | 0.026 |
Detection of New metastatic organ; 0 → 4 | 1.98 | 1.09–3.59 | 0.024 | NI | ||
New minor site metastases; absent vs. present | 8.44 | 1.21–58.8 | 0.031 | NI | ||
Hepatic metastases; absent vs. present | 5.50 | 0.94–32.2 | 0.059 | NI | ||
Minor site metastases; absent vs. present | 5.50 | 0.94–32.2 | 0.059 | NI | ||
Mutation site at initial diagnosis; Exon19 Deletion vs. L858R | 3.91 | 0.87–17.5 | 0.075 | 1.15 | 0.13–10.1 | 0.897 |
New hepatic metastases; absent vs. present | 5.00 | 0.62–40.3 | 0.131 | NI |